These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A High-Throughput Radioactivity-Based Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex. Khalili Yazdi A, Li F, Devkota K, Perveen S, Ghiabi P, Hajian T, Bolotokova A, Vedadi M. SLAS Discov; 2021 Jul; 26(6):757-765. PubMed ID: 33874769 [Abstract] [Full Text] [Related]
23. Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs. Narayanan N, Nair DT. Int J Biol Macromol; 2021 Jan 31; 168():272-278. PubMed ID: 33309661 [Abstract] [Full Text] [Related]
25. The Chameleon Strategy-A Recipe for Effective Ligand Screening for Viral Targets Based on Four Novel Structure-Binding Strength Indices. Latosińska M, Latosińska JN. Viruses; 2024 Jul 03; 16(7):. PubMed ID: 39066235 [Abstract] [Full Text] [Related]
27. Computational investigation of potent inhibitors against SARS-CoV-2 2'-O-methyltransferase (nsp16): Structure-based pharmacophore modeling, molecular docking, molecular dynamics simulations and binding free energy calculations. Shi L, Wen Z, Song Y, Wang J, Yu D. J Mol Graph Model; 2022 Dec 03; 117():108306. PubMed ID: 36063745 [Abstract] [Full Text] [Related]
28. Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry. Scholle MD, Liu C, Deval J, Gurard-Levin ZA. SLAS Discov; 2021 Jul 03; 26(6):766-774. PubMed ID: 33870746 [Abstract] [Full Text] [Related]
29. Structure-guided optimization of adenosine mimetics as selective and potent inhibitors of coronavirus nsp14 N7-methyltransferases. Hausdorff M, Delpal A, Barelier S, Nicollet L, Canard B, Touret F, Colmant A, Coutard B, Vasseur JJ, Decroly E, Debart F. Eur J Med Chem; 2023 Aug 05; 256():115474. PubMed ID: 37192550 [Abstract] [Full Text] [Related]
30. Structures of SARS-CoV-2 N7-methyltransferase with DOT1L and PRMT7 inhibitors provide a platform for new antivirals. Kottur J, White KM, Rodriguez ML, Rechkoblit O, Quintana-Feliciano R, Nayar A, García-Sastre A, Aggarwal AK. PLoS Pathog; 2023 Jul 05; 19(7):e1011546. PubMed ID: 37523415 [Abstract] [Full Text] [Related]
31. Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-Methyltransferase. Kasprzyk R, Spiewla TJ, Smietanski M, Golojuch S, Vangeel L, De Jonghe S, Jochmans D, Neyts J, Kowalska J, Jemielity J. Antiviral Res; 2021 Sep 05; 193():105142. PubMed ID: 34303749 [Abstract] [Full Text] [Related]
32. Discovery of SARS-CoV-2 Nsp14 and Nsp16 Methyltransferase Inhibitors by High-Throughput Virtual Screening. Bobrovs R, Kanepe I, Narvaiss N, Patetko L, Kalnins G, Sisovs M, Bula AL, Grinberga S, Boroduskis M, Ramata-Stunda A, Rostoks N, Jirgensons A, Tars K, Jaudzems K. Pharmaceuticals (Basel); 2021 Nov 30; 14(12):. PubMed ID: 34959647 [Abstract] [Full Text] [Related]
38. Structure-function analysis of severe acute respiratory syndrome coronavirus RNA cap guanine-N7-methyltransferase. Chen Y, Tao J, Sun Y, Wu A, Su C, Gao G, Cai H, Qiu S, Wu Y, Ahola T, Guo D. J Virol; 2013 Jun 30; 87(11):6296-305. PubMed ID: 23536667 [Abstract] [Full Text] [Related]
39. 3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors. Bobileva O, Bobrovs R, Sirma EE, Kanepe I, Bula AL, Patetko L, Ramata-Stunda A, Grinberga S, Jirgensons A, Jaudzems K. Molecules; 2023 Jan 12; 28(2):. PubMed ID: 36677825 [Abstract] [Full Text] [Related]
40. Porcine Epidemic Diarrhea Virus Deficient in RNA Cap Guanine-N-7 Methylation Is Attenuated and Induces Higher Type I and III Interferon Responses. Lu Y, Cai H, Lu M, Ma Y, Li A, Gao Y, Zhou J, Gu H, Li J, Gu J. J Virol; 2020 Jul 30; 94(16):. PubMed ID: 32461321 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]